Ablacon
@AblaconInc
Followers
17
Following
7
Media
2
Statuses
7
At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.
Joined January 2023
RT @CortexEP: To hear more about our new RESOLVE-AF trial, listen to this recent episode of the MassDevice Fast Five podcast. The segment o….
0
1
0
RT @CortexEP: Excited to announce the initiation of our RESOLVE-AF trial. This trial aims to demonstrate that EGF mapping can be used to id….
prnewswire.com
/PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international,...
0
1
0
RT @CortexEP: Thanks to @MichelleF_Davis @Bloomberg for breaking the story on the formation of Cortex to pursue a fully integrated solution….
bloomberg.com
Ajax Health has established a new medical technology company to develop a treatment for the most common heart rhythm disorder.
0
2
0
RT @CortexEP: Announcing the formation of Cortex, a new comprehensive AFib ablation technology company, with $90M investment led by KKR & H….
prnewswire.com
/PRNewswire/ -- Ajax Health announced today the formation and funding of Cortex, a medical technology company developing an integrated mapping and ablation...
0
2
0
RT @MelissaKongMD: @AblaconInc @dhaines901 @ikutinsky1 The RESOLVE-AF clinical study is off to a great start--Big thanks and congratulation….
0
1
0
First 3 patients successfully enrolled in the RESOLVE-AF clinical study by Dr. David Haines @dhaines901 and Dr. Ilana Kutinsky @ikutinsky1 this week. The trial evaluates #Ablacon EGF mapping to identify extra-pulmonary vein sources of AF and guide #AFablation therapy. #EPeeps
1
3
5
Join us at the @AFSymposium as @VivekReddyMD presents “FLOW-AF: A Randomized Controlled Trial of Electrographic Flow-Guided Ablation in Redo Patients with Non-Paroxysmal Atrial Fibrillation” on Friday, at 5pm EST at the Late Breaking Clinical Trials Session #epeeps #medtech #afib
1
2
7